Tovorafenib (Ojemda): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Tovorafenib (Ojemda) is a precision cancer therapy known as a pan-RAF inhibitor. This article is about its uses in cancer, side effects, dosage.

Tovorafenib (Ojemda): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/tovora...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Tovorafenib #Ojemda #BrainTumors #Glioma #FDAApproval

BRAF-Targeted Drug Approved for Pediatric Low-Grade Glioma FDA has granted an accelerated approval to tovorafenib (Ojemda) for kids and teens who have low-grade glioma with changes in the BRAF gene.

#MedSky🧪 #PedSky #Childhoodcancer FDA granted accelerated approval to #tovorafenib (#Ojemda) for kids aged 6 months or older who have low-grade #glioma, a type of brain tumor, with changes in a gene called #BRAF.
www.cancer.gov/news-events/...